IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lakeshore Biopharma Co LTD

CUSIP: G9845F208 | 10 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ACrystal Peak Holdings Inc.00.0%Fell below 5%Jun 24, 2026No 13F filer matched
13D/ACrystal Peak Holdings Inc.0
0.0% of class · Jun 24, 2026

Institutional Holders — Q3 2025

Barclays PLC24,757
0.0% of portfolio›$18.1K
StyleTurnoverLocationFiled
Barclays PLC
24,757$18.1K0.0%CoreMediumLondon, United Kingdom2026-03-31
Fell below 5%
No 13F filer matched